5-Formylcytosine and 5-hydroxymethyluracil as surrogate markers of TET2 and SF3B1 mutations in myelodysplastic syndrome, respectively.

5-Formylcytosine and 5-hydroxymethyluracil as surrogate markers of TET2 and SF3B1 mutations in myelodysplastic syndrome, respectively. Haematologica. 2019 Sep 05;: Authors: Gackowski D, Gawronski M, Kerr C, Radivoyevitch T, Zarakowska E, Starczak M, Abakir A, Ruzov A, Maciejewski JP, Olinski R Abstract PMID: 31488558 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31488558?dopt=Abstract

Source: Haematologica - September 4, 2019 Category: Hematology Authors: Gackowski D, Gawronski M, Kerr C, Radivoyevitch T, Zarakowska E, Starczak M, Abakir A, Ruzov A, Maciejewski JP, Olinski R Tags: Haematologica Source Type: research

More News: Hematology | Myelodysplastic Syndrome